Medical News Today,
Article Date: 17 Apr 2010 - 0:00 PDT
A new technique for reprogramming human adult cells could greatly improve the safety and efficiency of producing patient-specific stem cells for use in a range of therapeutic applications to repair or replace damaged or diseased tissues.
Original paper full text pdf
Thursday, April 22, 2010
Wednesday, April 21, 2010
Structural basis for Fe-S cluster assembly and tRNA thiolation mediated by IscS protein-protein interactions.
PLoS Biol. 2010 Apr 13;8(4):e1000354.
Highlight: "Our data support the role of frataxin as an iron donor for IscU to form the Fe-S clusters."
FULL TEXT PDF
Rong Shi1, Ariane Proteau1, Magda Villarroya2, Ismaïl Moukadiri2, Linhua Zhang3, Jean-François Trempe1, Allan Matte3, M. Eugenia Armengod2, Miroslaw Cygler1,3*
1 Department of Biochemistry, McGill University, Montréal, Québec, Canada, 2 Laboratorio de Genética Molecular, Centro de Investigación Príncipe Felipe, Valencia, Spain, 3 Biotechnology Research Institute, Montréal, Québec, Canada
OPEN ACCES
FULL TEXT PDF
Tuesday, April 20, 2010
A New Proposal For Achieving Neuronal Regeneration
Medical News Today, Article Date: 20 Apr 2010 - 2:00 PDT
Over the past four years, in the installations of the Faculty of Medicine, University of Cadiz, a group of researchers, headed by Doctor Carmen Estrada, has been studying neurogenesis the process of forming new neurons from mother cells in the adult mammal brain. The purpose of this research project is to contribute to the knowledge of this process with the object of finding some additional mechanism that would facilitate the treatment of pathologies of the central nervous system (CNS) that are suffered in consequence of neuronal death...
Over the past four years, in the installations of the Faculty of Medicine, University of Cadiz, a group of researchers, headed by Doctor Carmen Estrada, has been studying neurogenesis the process of forming new neurons from mother cells in the adult mammal brain. The purpose of this research project is to contribute to the knowledge of this process with the object of finding some additional mechanism that would facilitate the treatment of pathologies of the central nervous system (CNS) that are suffered in consequence of neuronal death...
Frataxin, the mitochondrial iron chaperone for Fe-S cluster bioassembly
ProQuest, Dissertations & Theses
Jeremy David, Ph.D.,Wayne State University, 2010, 256 pages; AAT 3390960
Jeremy David, Ph.D.,Wayne State University, 2010, 256 pages; AAT 3390960
Keywords: Iron, human disorders and diseases, Freidreich's Ataxia (FRDA),
frataxin, mitochondria, iron homeostasis, chaperone, Iron Sulfur Cluster (ISC), ferrous iron, carboxylate ligands
Saturday, April 17, 2010
Erhaltene Reflexe, Propriozeption, SNAPs: trotzdem Friedreich-Ataxie - [Retained reflexes, proprioception, SNAPs: still Friedreich's ataxia]
Nervenarzt. 2010 Apr;81(4):442-3.
DOI: 10.1007/s00115-010-2946-3
Article in German
FULL TEXT PDF
DOI: 10.1007/s00115-010-2946-3
K. Dimitriadis1, 2, S. Heck2, M. Schubert1 und T. Klopstock1, 2
| (1) | Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik, Klinikum der Universität München – Innenstadt, Ziemssenstraße 1a, 80336 München |
| (2) | Neurologische Klinik und Poliklinik, Klinikum der Universität München – Großhadern, München |
Article in German
FULL TEXT PDF
Repligen Corporation - HDAC-3 Inhibitors for Friedreich's Ataxia
WALTHAM, Mass., April 16, 2010 /PRNewswire via COMTEX/ -- Repligen Corporation
.../...
HDAC-3 Inhibitors for Friedreich's Ataxia
We are currently developing inhibitors of histone deacetylase 3 (HDAC-3) for the treatment of inherited neurodegenerative diseases such as Friedreich's ataxia. Preclinical studies have shown that specific HDAC-3 inhibitors increase production of the protein frataxin which may have the potential to arrest disease progression in patients with Friedreich's ataxia. We plan to file an Investigational New Drug Application (IND) for a Phase 1 human clinical study of RG2833 in healthy volunteers this quarter.
.../...
.../...
HDAC-3 Inhibitors for Friedreich's Ataxia
We are currently developing inhibitors of histone deacetylase 3 (HDAC-3) for the treatment of inherited neurodegenerative diseases such as Friedreich's ataxia. Preclinical studies have shown that specific HDAC-3 inhibitors increase production of the protein frataxin which may have the potential to arrest disease progression in patients with Friedreich's ataxia. We plan to file an Investigational New Drug Application (IND) for a Phase 1 human clinical study of RG2833 in healthy volunteers this quarter.
.../...
Intermediate-Dose Idebenone and Quality of Life in Friedreich Ataxia
Pediatric Neurology
Volume 42, Issue 5, May 2010, Pages 338-342
n F. Brandsema MD*, Derek Stephens MSc†, Jessica Hartley MSc‡ and Grace Yoon MD*, ‡
Volume 42, Issue 5, May 2010, Pages 338-342
n F. Brandsema MD*, Derek Stephens MSc†, Jessica Hartley MSc‡ and Grace Yoon MD*, ‡
† Department of Child Health Evaluative Sciences, The Hospital for Sick Children, University of Toronto, Toronto, Canada
‡ Division of Clinical and Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada
* Division of Neurology, The Hospital for Sick Children, University of Toronto, Toronto, Canada
Keywords: Idebenone, Friedreich ataxia, neurologic function, cardiac function, quality of life, 20 mg/kg per day, Pediatric Quality of Life Inventory, International Cooperative Ataxia Rating Scale, Activities of Daily Living Scale.
‡ Division of Clinical and Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada
* Division of Neurology, The Hospital for Sick Children, University of Toronto, Toronto, Canada
Keywords: Idebenone, Friedreich ataxia, neurologic function, cardiac function, quality of life, 20 mg/kg per day, Pediatric Quality of Life Inventory, International Cooperative Ataxia Rating Scale, Activities of Daily Living Scale.
Health-Related Quality of Life in Children With Friedreich Ataxia
Friday, April 16, 2010
Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation.
Can J Physiol Pharmacol. 2010 Mar;88(3):187-96.
Keywords: Iron, mitochondria, neurodegeneration, frataxin, Friedreich's ataxia (FRDA), iron chelation, deferiprone (DFP), iron-relocating abilities, cellular iron misdistribution.
Kakhlon O, Breuer W, Munnich A, Cabantchik ZI.
Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Safra Campus at Givat Ram, Jerusalem 91904, Israel.
Keywords: Iron, mitochondria, neurodegeneration, frataxin, Friedreich's ataxia (FRDA), iron chelation, deferiprone (DFP), iron-relocating abilities, cellular iron misdistribution.
Thursday, April 15, 2010
Efficacy of Riluzole in Hereditary Cerebellar Ataxia - This study is currently recruiting participants.
www.clinicaltrials.gov
This study is currently recruiting participants.
Verified by S. Andrea Hospital, April 2010
First Received: April 7, 2010 Last Updated: April 14, 2010
| Sponsor: | S. Andrea Hospital |
|---|---|
| Information provided by: | S. Andrea Hospital |
| ClinicalTrials.gov Identifier: | NCT01104649 |
Subscribe to:
Posts (Atom)
